274 related articles for article (PubMed ID: 14534075)
21. Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7-37) on a somatostatin secreting cell line.
Fehmann HC; Habener JF
FEBS Lett; 1991 Feb; 279(2):335-40. PubMed ID: 1672112
[TBL] [Abstract][Full Text] [Related]
22. Glucose and glucoincretin peptides synergize to induce c-fos, c-jun, junB, zif-268, and nur-77 gene expression in pancreatic beta(INS-1) cells.
Susini S; Roche E; Prentki M; Schlegel W
FASEB J; 1998 Sep; 12(12):1173-82. PubMed ID: 9737720
[TBL] [Abstract][Full Text] [Related]
23. A cAMP and Ca2+ coincidence detector in support of Ca2+-induced Ca2+ release in mouse pancreatic beta cells.
Kang G; Chepurny OG; Rindler MJ; Collis L; Chepurny Z; Li WH; Harbeck M; Roe MW; Holz GG
J Physiol; 2005 Jul; 566(Pt 1):173-88. PubMed ID: 15860526
[TBL] [Abstract][Full Text] [Related]
24. Constitution of a biphasic insulin response to glucose in human fetal pancreatic beta-cells with glucagon-like peptide 1.
Otonkoski T; Hayek A
J Clin Endocrinol Metab; 1995 Dec; 80(12):3779-83. PubMed ID: 8530635
[TBL] [Abstract][Full Text] [Related]
25. GLP-1(7-36)amide-stimulated insulin secretion in rat islets is sodium-dependent.
Fridolf T; Ahrén B
Biochem Biophys Res Commun; 1991 Aug; 179(1):701-6. PubMed ID: 1883392
[TBL] [Abstract][Full Text] [Related]
26. Effects of glucagon like peptide-1(7-36) amide on the cytoplasmic Ca(2+)-concentration in rat islet cells.
Fridolf T; Ahrén B
Mol Cell Endocrinol; 1993 Oct; 96(1-2):85-90. PubMed ID: 8276143
[TBL] [Abstract][Full Text] [Related]
27. Glucose-dependent alterations of intracellular free calcium by glucagon-like peptide-1(7-36amide) in individual ob/ob mouse beta-cells.
Cullinan CA; Brady EJ; Saperstein R; Leibowitz MD
Cell Calcium; 1994 May; 15(5):391-400. PubMed ID: 8033197
[TBL] [Abstract][Full Text] [Related]
28. Incretin hormones regulate glucose-dependent insulin secretion in RIN 1046-38 cells: mechanisms of action.
Montrose-Rafizadeh C; Egan JM; Roth J
Endocrinology; 1994 Aug; 135(2):589-94. PubMed ID: 8033807
[TBL] [Abstract][Full Text] [Related]
29. GLP-1(7-36) amide stimulates insulin secretion in rat islets: studies on the mode of action.
Fridolf T; Ahrén B
Diabetes Res; 1991 Apr; 16(4):185-91. PubMed ID: 1802486
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells.
Morgan DG; Kulkarni RN; Hurley JD; Wang ZL; Wang RM; Ghatei MA; Karlsen AE; Bloom SR; Smith DM
Diabetologia; 1998 Dec; 41(12):1482-91. PubMed ID: 9867216
[TBL] [Abstract][Full Text] [Related]
31. Glucagon-like peptide-1 stimulates insulin secretion but not phosphoinositide hydrolysis from islets desensitized by prior exposure to high glucose or the muscarinic agonist carbachol.
Zawalich WS; Zawalich KC
Metabolism; 1996 Feb; 45(2):273-8. PubMed ID: 8596502
[TBL] [Abstract][Full Text] [Related]
32. A novel insulin secretagogue is a phosphodiesterase inhibitor.
Leibowitz MD; Biswas C; Brady EJ; Conti M; Cullinan CA; Hayes NS; Manganiello VC; Saperstein R; Wang LH; Zafian PT
Diabetes; 1995 Jan; 44(1):67-74. PubMed ID: 7813816
[TBL] [Abstract][Full Text] [Related]
33. Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic beta-cells by both proximal and distal regulatory steps in stimulus-secretion coupling.
Gromada J; Bokvist K; Ding WG; Holst JJ; Nielsen JH; Rorsman P
Diabetes; 1998 Jan; 47(1):57-65. PubMed ID: 9421375
[TBL] [Abstract][Full Text] [Related]
34. Regulation of glucagon and glucagon-like peptide-1 receptor messenger ribonucleic acid expression in cultured rat pancreatic islets by glucose, cyclic adenosine 3',5'-monophosphate, and glucocorticoids.
Abrahamsen N; Nishimura E
Endocrinology; 1995 Apr; 136(4):1572-8. PubMed ID: 7534705
[TBL] [Abstract][Full Text] [Related]
35. Interaction of glucagon-like peptide-I (GLP-I) and galanin in insulin (beta TC-1)- and somatostatin (RIN T3)-secreting cells and evidence that both peptides have no receptors on glucagon (INR1G9)-secreting cells.
Fehmann HC; Janssen M; Göke B
Acta Diabetol; 1995 Oct; 32(3):176-81. PubMed ID: 8590787
[TBL] [Abstract][Full Text] [Related]
36. Glucagon-like peptide I and glucose-dependent insulinotropic polypeptide stimulate Ca2+-induced secretion in rat alpha-cells by a protein kinase A-mediated mechanism.
Ding WG; Renström E; Rorsman P; Buschard K; Gromada J
Diabetes; 1997 May; 46(5):792-800. PubMed ID: 9133546
[TBL] [Abstract][Full Text] [Related]
37. Effects of glucagonlike peptide I-(7-36) on release of insulin, glucagon, and somatostatin by rat pancreatic islet cell monolayer cultures.
D'Alessio DA; Fujimoto WY; Ensinck JW
Diabetes; 1989 Dec; 38(12):1534-8. PubMed ID: 2573553
[TBL] [Abstract][Full Text] [Related]
38. Glucagon-like peptide-1 (GLP-1): a gut hormone of potential interest in the treatment of diabetes.
Ahrén B
Bioessays; 1998 Aug; 20(8):642-51. PubMed ID: 9780839
[TBL] [Abstract][Full Text] [Related]
39. cAMP-signaling pathway acts in selective synergism with glucose or tolbutamide to increase cytosolic Ca2+ in rat pancreatic beta-cells.
Yaekura K; Kakei M; Yada T
Diabetes; 1996 Mar; 45(3):295-301. PubMed ID: 8593933
[TBL] [Abstract][Full Text] [Related]
40. Influence of glucagon-like peptide-1 on beta cell responsiveness.
Zawalich WS; Zawalich KC; Rasmussen H
Regul Pept; 1993 Apr; 44(3):277-83. PubMed ID: 8484020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
